Ratings CLIO Cosmetics Co.,Ltd

Equities

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
36,850 ^KRW	+1.80%		+8.06%	+19.64%

19/04	CLIO Cosmetics Co.,Ltd agreed to acquire Doowon for KRW 7.05 billion.	CI
21/03	CLIO Cosmetics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 54% by 2026.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts covering this company mostly recommend stock overweighting or purchase.
Over the past four months, analysts' average price target has been revised upwards significantly.

The company is not the most generous with respect to shareholders' compensation.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
The group usually releases earnings worse than estimated.

	1st Jan change	Capi.	ESG Refinitiv
CLIO COSMETICS CO.,LTD	+19.64%	473M	-
L'ORÉAL	+1.36%	264B	B-
KAO CORPORATION	+18.26%	20.44B	B+
SHISEIDO COMPANY, LIMITED	+11.36%	12.29B	A-
COTY INC.	-12.64%	9.5B	A-
AMOREPACIFIC CORPORATION	+16.55%	7.6B	B+
PROYA COSMETICS CO.,LTD.	+11.43%	6.16B	B
NATURA &CO HOLDING S.A.	-2.43%	4.24B	B+
INTER PARFUMS, INC.	-13.62%	3.92B	C-
KOSÉ CORPORATION	-7.58%	3.67B	B

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality